Industry NewsLife Sciences
ERS Genomics and StemSight sign CRISPR/Cas9 license agreement
License agreement provides StemSight access to CRISPR/Cas9 technology to be applied in the development of cell therapies for corneal blindness
News & Articles
Results per page
25
7 Articles Found | Selected Filters:
Industry NewsLife Sciences
ERS Genomics and Japan SLC sign CRISPR/Cas9 license agreement
Nobel prize winning CRISPR technology to be applied in development of genetically engineered animal models
Industry NewsLife Sciences
ERS Genomics and GenScript Biotech Corporation sign CRISPR/Cas9 license agreement
License agreement to enhance GenScript’s CRISPR offering for gene and cell therapy research
Industry NewsLife Sciences
ERS Genomics and ZeClinics sign CRISPR/Cas9 license agreement
The license from ERS expands ZeClinics CRISPR IP portfolio and increases the validity and potency of zebrafish models for the drug discovery process
